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The use of aloe vera in cancer radiation: An updated comprehensive review
Abstract
Introduction: Many cancer patients require radiation therapy and often experience adverse effects
including erythema, itching, and pain. Aloe vera has been studied for its potential use in the prevention
and treatment of radiation related adverse effects as it possesses a variety of properties and is
considered an antioxidant and anti-inflammatory agent. Multiple controlled trials have been performed in
order to evaluate the efficacy of aloe vera for the prevention and treatment of radiation side effects.
Previous systematic reviews have examined the use of aloe vera for radiation-induced skin reactions,
however updated literature now includes the use of aloe vera in proctitis.
Objectives: The aim of this comprehensive review is to summarize and evaluate the use of aloe vera in
patients who have undergone radiation therapy for the treatment of cancer.
Results: Aloe vera may not be effective for prophylaxis or treatment of radiation adverse effects in breast
cancer patients. Moderate efficacy was seen when aloe vera was used in combination with mild soap
versus soap as monotherapy for the treatment of radiation skin reactions. Aloe vera may be effective
when cumulative radiation doses are greater than 2,700cGy and for acute radiation proctitis.
Conclusions: There is contradictory evidence for the use of aloe vera in the setting of radiation in regards
to its efficacy in the prevention and treatment of radiation-induced adverse effects.
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Abstract
Introduction: Many cancer patients require radiation therapy and often experience
adverse effects including erythema, itching, and pain. Aloe vera has been studied for its
potential use in the prevention and treatment of radiation related adverse effects as it
possesses a variety of properties and is considered an antioxidant and antiinflammatory agent. Multiple controlled trials have been performed in order to evaluate
the efficacy of aloe vera for the prevention and treatment of radiation side effects.
Previous systematic reviews have examined the use of aloe vera for radiation-induced
skin reactions, however updated literature now includes the use of aloe vera in proctitis.
Objectives: The aim of this comprehensive review is to summarize and evaluate the use
of aloe vera in patients who have undergone radiation therapy for the treatment of
cancer.
Results: Aloe vera may not be effective for prophylaxis or treatment of radiation adverse
effects in breast cancer patients. Moderate efficacy was seen when aloe vera was used
in combination with mild soap versus soap as monotherapy for the treatment of
radiation skin reactions. Aloe vera may be effective when cumulative radiation doses
are greater than 2,700cGy and for acute radiation proctitis.
Conclusions: There is contradictory evidence for the use of aloe vera in the setting of
radiation in regards to its efficacy in the prevention and treatment of radiation-induced
adverse effects.
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1. Introduction
Aloe vera, or aloe barbadensis, is a herbal substance part of the Liliaceal family,
which contains over 300 species [1]. Aloe vera is commonly known for its topical use in
the treatment of burn injuries due to anti-inflammatory, antioxidant, and antibacterial
properties [2,3]. The mechanism of action for aloe vera is not fully known, however it is
speculated that inhibition of cyclooxygenase may play a role [2,4]. Inhibition of
cyclooxygenase may contribute to aloe vera’s anti-inflammatory and antioxidant
properties and as such it has the ability to treat burns and accelerate wound healing [2].
Aloe vera may also play a role in leukocyte and platelet aggregation causing a decrease
in vasoconstriction, which also contributes to wound healing [3]. The mechanism of
action of aloe vera allows for a variety of pharmacological claims and therefore has a
wide range of therapeutic uses which include, but are not limited to, arthritis, asthma,
candida, digestive bowel disorders, skin problems, and ulcers [1]. The ability of aloe
vera to mitigate the negative impact of radiation is now being evaluated in clinical trials.
Radiation is often a critical addition to chemotherapeutic regimens in order to
increase the efficacy of treatment and in some cases may be used as the sole
therapeutic modality. Approximately two-thirds of cancer patients will require the use of
radiation [5]. Radiation causes DNA damage, and subsequently the formation of free
radicals and anti-inflammatory responses at the site of action [6]. Radiation can have a
series of adverse effects including acute reactions that may occur within hours of
radiation therapy [7]. Acute reactions are generally defined as cutaneous adverse
effects including but not limited to itching or erythema and ranging in severity from mild
to exceptionally painful [3]. Acute adverse reactions are caused by damage to the
epidermal basal layer of the skin [3]. The squamous cells that are formed in this layer
migrate to the outermost layer of the epidermis and are eventually shed at a faster than
skin that has not been exposed to radiation [3]. This shedding process causes the skin
to become dry and cracked, which may cause pruritus and also pain [3].
Aloe vera is comprised of over 70 active components including anthraquinones,
vitamins, nonessential amino acids, essential amino acids, and inorganic compounds
[1]. The wide variety of aloe vera constituents allow for aloe vera to penetrate skin
tissue and also provide essential nutrients to the skin [1]. It is thought that aloe vera can
ameliorate radiation adverse events on the epidermis and dermis due to its wound
healing enhancement properties [6]. Aloe vera’s ability to increase wound oxygenation
and minimize the amount of dead tissue at radiation sites allows it to potentially
counteract the negative adverse events of radiation therapy [3]. It is important to

understand effective prophylactic and treatment regimens in order to manage radiationinduced skin reactions.
To our knowledge there have not been any updated comprehensive or
systematic reviews on the use of aloe vera in cancer radiation to date. The aim of this
comprehensive review is to summarize and evaluate the current evidence behind the
use of aloe vera in patients receiving radiation for the treatment of cancer.
2. Objectives
The primary objective of this article is to review current literature on aloe vera
and its potential use for the prevention and treatment of radiation related adverse
events when used in the treatment of cancers.
3. Methods
3.1 Database and search strategies
The authors utilized PubMed, Google Scholar, clinicaltrials.gov, and EBSCO as
primary literature search tools. The search criteria that was utilized was: (aloe vera)
AND (cancer radiation).
3.2 Inclusion Criteria
1) Controlled trials using aloe vera in cancer radiation
2) Patients receiving aloe vera for the prevention or treatment of radiation
adverse effects
3) English language
3.3 Exclusion Criteria
1) Non-clinical trials
2) Non-human studies
3) Aloe vera used in mucositis from cancer radiation
4) Co-formulations containing aloe vera
4. Results
4.1 Study selection
We identified and screened 54 papers published in the years 1999-2017 by titles
and abstracts. Of these, 42 were excluded because they either did not evaluate aloe
vera as monotherapy, did not specifically use aloe vera for radiation adverse effects, or
evaluated aloe vera for mucositis caused by radiation. Mucositis was excluded due to
preexisting comprehensive reviews [8,9]. A previous systematic literature review for
aloe vera in radiation-induced skin reactions was conducted in 2005, however recent
information on proctitis has been published in 2017 [10]. All authors agreed upon the
remaining articles that are integrated into this review.

4.2 Results of individual studies
4.2.1 Breast Cancer
A 2015 phase III trial evaluated the effects for treatment of skin reactions in
patients undergoing radiation treatment for breast cancer [6]. A total of 248 patients
were randomized to three comparative arms; placebo (77 patients), aloe cream (81
patients), or powder (79 patients) [6]. High quality aloe cream was extracted to meet
International Aloe Science Council standards [6]. The powder arm consisted of
nonmetallic baby powder or cornstarch while the placebo cream contained Aquatrix II,
Lexamul 561 emulsifier, methyl paraben, dimethicone, isopropyl myristate, propylene
glycol, cetyl alcohol and stearic acid emulsifiers, and triethanolamine. [6]. Within one
week of receiving radiation treatment, patients in each study arm reported acute skin
reactions including erythema, dry and moist desquamation, and skin rashes [6]. The
overall mean of the Catterall Skin Scoring Profile (CSSP) groups was 6.27 for the
powder arm, 6.96 for the aloe arm (p=0.0227) and 6.99 for the placebo group (p=0.127)
[6]. This study showed that aloe cream was not beneficial for skin reactions caused by
radiation. These results were not considered clinically significant by the study authors
[6]. However, there was a statistically significant difference in pain scores from radiation
among the study arms. Nine of the sixty-seven patients in the powder group, twenty one
of seventy-two in the aloe group, and twenty five of seventy-four patients in the placebo
arm had high pain defined by the 6-point Likert tool (p=0.0163) [6]. Aloe vera did not
show statistical significance for preventing or decreasing skin reactions from cancer
radiation [6].
A 2007 study evaluated 50 females with breast cancer to determine if aloe vera
could mitigate the intensity of erythema caused by acute radiation dermatitis [11].
Erythema was evaluated using near infrared spectroscopy, laser doppler, and digital
color photography. The three study arms included aloe barbadensis 97% gel, essex
lotion, and no lotion. Neither aloe vera gel or essex lotion versus placebo showed
statistical significance for any of the methods used [11]. Aloe vera gel and essex lotion
did not have any clinical impact on erythema [11].
A 2002 phase III study examined if aloe vera gel had an effect on skin sideeffects on irradiated breast tissue. Two hundred and eight patients participated in this
study with 107 patients in the 98% aloe vera gel arm and 101 patients in the topical
aqueous cream arm [3]. Topical aloe vera gel was not statistically significant for
reducing symptoms of itching, pain, erythema, dry or moist desquamation in breast
cancer patients undergoing radiation [3].
In a 2017 prospective randomized controlled trial, aloe vera gel lacked
prophylactic properties when studied in breast cancer patients who had radiationinduced dermatitis [5]. Fifty patients were enrolled in the aloe vera gel arm while fifty

patients did not receive aloe vera treatment for a total of 100 study participants [5]. After
five weeks of therapy, 45 patients in the aloe vera arm and 47 patients in the control
arm had varying grades of dermatitis [5]. There were no statistical differences seen
between either treatment over the five week duration [5]. A summary of aloe vera
products used in breast cancer patients can be seen below in Table 1.
Table 1
Summary of Aloe Vera Products used in Patients with Breast Cancer
Author
Sample Medium
Composition
Volume
and Year
Size
Used
Hoopfer D.
et al, 2015

248

Cream

Nyström J.
et al, 2007

50

Gel

Heggie S.
et al, 2002

208

Ahmadloo
N. et al,
2017

100

Frequency and
Duration

30mg of
processed aloe
(1000-5000 MW
fraction) within
100mL of placebo
cream
97% aloe
barbadensis

Approximately
2.5mLs

Three times a
day throughout
radiation and for
1 month after
radiation

0.2mL

Gel

98% aloe vera

N/R

Gel

Aloe vera and 1%
additive materials
including pectin,
vitamin C, and
Natamycin

1-2mm on
radiation site

Twice a day on
every treatment
day
Three times a
day during
radiation and for
two weeks after
radiation
completion
Twice a day in a
minimum of 6
hour intervals

N/R = not reported by authors
4.2.2 Proctitis
Radiation of the pelvic area may cause acute radiation proctitis (ARP) in up to
50% of patients and can present with a variety of symptoms including pain, abdominal
cramping, diarrhea, and rectal bleeding [2]. In a 2017 randomized, double-blind,
prospective, placebo-controlled trial, the use of aloe vera was evaluated revealing
successful treatment of acute radiation proctitis. The study enrolled 20 patients, 9 in the
aloe group and 11 in the placebo group, and all experienced ARP [2].
The active arm used was aloe vera 3% gel powder in white paraffin; patients
receiving topical aloe vera greatly improved from a total clinical presentation score of
4.3 (SEM 2.2) to 1.2 (SEM 0.8) by week four of treatment [2]. The placebo group was

almost unchanged with a total clinical presentation score of 4.2 (SEM 1.2) to 3.5 (SEM
1.1) by week four of treatment [2]. Total clinical presentation included hemorrhage,
abdominal rectal pain, diarrhea, and fecal urgency and the differences in the two arms
were statistically significant (p=0.0087) [2]. Diarrhea was the most commonly prevented
ARP symptom (p=0.008) [2]. Patients treated with aloe vera have almost four times
higher odds of experiencing a decrease in overall clinical presentation compared to
patients not treated with aloe vera (OR 3.97, 95% CI 1.3-11.9) [2].
The Radiation Therapy Oncology Group (RTOG) score showed a similar trend
with a score of 2.89 (SEM: 2.1) to 0.89 (SEM: 1.0) in the aloe vera arm [2]. Aloe vera
had almost six times higher odds of a decreased RTOG score compared to the placebo
arm (p=0.0016, OR 5.9, 95% CI 1.6-21.6) [2]. The authors concluded that topical 3%
aloe vera was determined to be safe and effective for proctitis including ARP symptoms
in patients undergoing radiation therapy. A summary of aloe vera products used in
proctitis can be seen below in Table 2.
Table 2
Summary of Aloe Vera Products used in Patients with Proctitis
Author and
Sample Medium
Composition
Year
Size
Used

Sahebnasagh
A. et al, 2017

20

Ointment

9 grams of aloe vera
powder levigated with 7
grams of liquid white
paraffin and
geometrically mixed with
284 grams of vaseline to
yield the ointment aloe
vera gel powder 3%

Volume

Frequency
and
Duration

1 gram

Applied
twice a day
for four
weeks

4.2.3 Breast, pelvic, head-and-neck cancer combination
A total of 60 patients were evaluated in a 2013 self-controlled clinical trial after
receiving five weeks of radiation for head-and-neck, breast and pelvic cancers [12].
Patients were instructed to apply commercially available aloe lotion to only one side of
their body twice a day with nothing used on the other half of their body [12]. Dermatitis
on the aloe side was grade 1, grade 2, and grade 3 in 42, 32, and 17 people,
respectively. The control side of the body showed a grade 1, grade 2, and grade 3 in 32,
17, and 1 person, respectively [12]. The RTOG acute radiation morbidity scoring criteria
was used for dermatitis grading [12]. Overall, aloe vera showed statistical significance in
week four (p<0.000), week five (p<0.000) and week six (p<0.006) [12]. It was concluded
that aloe vera lotion has protective properties against radiation-induced dermatitis [12].

A 2001 randomized, prospective, blinded trial included seventy-three patients
who had cancer of the head/neck, chest, abdomen/pelvis, or in the extremities. Patients
were randomized to receive 100% pure aloe vera gel (n=33) or placebo (n=40) and all
patients were instructed to wash with mild soap. There was no statistical differences in
skin changes when looking at variables including chemotherapy, skin texture, erythema,
itching, and skin tanning [13]. There was also no statistical significance when evaluating
the skin change in correlation to the dose toxicity of radiation (p=0.189) [13]. Nineteen of
twenty two patients (86%) in the aloe vera/soap arm showed moderate skin changes
[13]. Cumulative radiation doses greater than 2,700cGy showed statistical significance
(p=0.0130) [13]. Forty-four percent of patients in the aloe/soap arm went four weeks
before any skin changes occurred compared to the soap alone arm, this pattern was not
seen at cumulative radiation doses less than 2,700cGy (p=0.4336) [13]. The trial
showed the benefits of using 100% pure aloe vera gel to protect patients from radiation
dermatitis, especially with cumulative radiation doses over 2,700cGy [13]. A summary of
aloe vera products used in breast, pelvic, head-and-neck cancer combinations can be
seen below in Table 3.
Table 3
Summary of Aloe Vera Products used in Patients with Breast, Pelvic, Head-and-Neck
Cancer Combinations
Author Sample Medium Used
Composition
Volume
Frequency
and
Size
and Duration
Year
Haddad
P. et al,
2013

60

Commerciallyavailable lotion

Olsen
DL. et
al, 2001

73

Gel

Aloe vera along with
additives such as
lanolin oil, glyceryl
stearate, diluted
collagen,
tocopherol,
allantoin, and
paraben
100% pure aloe
vera

On one
half of
the body

Twice daily
from the
beginning of
radiation and
for two weeks
after radiation

Applied
the gel
liberally

Each day
following
radiation
treatment

5. Discussion
Seven studies were included in this comprehensive literature review of aloe vera
in the prevention and treatment of radiation-induced adverse effects. Four studies
specifically looked at breast cancer patients undergoing radiation. All four suggest that

aloe vera is not useful for radiation adverse effects in breast cancer patients [3,5,6,11].
One controlled trial showed success for treatment of acute radiation proctitis with aloe
vera [2]. Two studies evaluated a variety of radiation sites including head/neck, chest,
and abdomen. One study showed that aloe vera gel used with mild soap may be
effective, especially with cumulative radiation doses over 2,700cGy [13]. The second
study also showed that aloe vera can reduce radiation-induced dermatitis when used
prophylactically [12]. A major limitation of the reviewed studies is their small sample
size. Future large randomized clinical trials would be useful in determining if aloe vera is
consistently useful in preventing and treating radiation adverse effects. Another
limitation is that the authors did not identify how they decided on the amount of aloe
vera that should be used in order to have proper absorption at radiation sites.
6. Conclusions
Based on the trials found in this review, there is conflicting evidence as to
whether or not aloe vera can prevent or treat radiation-induced adverse effects. Aloe
vera was not found to be consistently effective for radiation effects in breast cancer
patients. Conversely, aloe vera seems to be effective for acute radiation proctitis, but
further large randomized controlled trials will be necessary to make a more definitive
recommendation.
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